HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Focal therapy for prostate cancer in Germany - 2014 status].

AbstractBACKGROUND:
In localized low-risk prostate cancer (PCa), there is a therapeutic dilemma between possible overtreatment by one of the standard therapies and potentially insufficient cancer control by active surveillance (AS). Focal therapy (FT) provides an alternative therapeutic option as it aims to preserve the organ and to eliminate the cancer focus at the same time.
METHODS:
In this article the current state of FT for localized low-risk prostate carcinoma in Germany is described. In addition, criteria that should be used to select patients for FT are proposed.
RESULTS:
Currently, the effectiveness of FT is under evaluation by two multicenter, prospective studies in Germany: TOOKAD and HEMI. However, localized low-risk prostate carcinoma remains a diagnostic challenge: Multiparametric MRI as well as histopathological second opinion are considered mandatory in addition to transrectal biospy.
CONCLUSION:
The oncological outcome of both the TOOKAD and HEMI study will be crucial for any form of FT for prostate carcinoma in Germany in the future. However, there is a remarkably high acceptance of FT among patients.
AuthorsA Roosen, R Ganzer, B Hadaschik, J Köllermann, A Blana, T Henkel, A-B Liehr, D Baumunk, S Machtens, G Salomon, L Sentker, U Witsch, K U Köhrmann, M Schostak, Arbeitskreis für Fokale und Mikrotherapie der Akademie der Deutschen Gesellschaft für Urologie e.V
JournalDer Urologe. Ausg. A (Urologe A) Vol. 53 Issue 7 Pg. 1040-5 (Jul 2014) ISSN: 1433-0563 [Electronic] Germany
Vernacular TitleFokale Therapie des Prostatakarzinoms in Deutschland - Status 2014.
PMID24941932 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Evidence-Based Medicine
  • Germany
  • Humans
  • Male
  • Minimally Invasive Surgical Procedures (methods)
  • Organ Sparing Treatments (methods)
  • Prognosis
  • Prostatectomy (methods)
  • Prostatic Neoplasms (diagnosis, therapy)
  • Radiotherapy, Conformal (methods)
  • Risk Assessment (methods)
  • Treatment Outcome
  • Watchful Waiting (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: